Image taken from Roche website http://www.roche.com/research_and_development/drawn_to_science/target_identification.htm

Rethinking Drug Discovery & Research Models in India

Drug discovery is a high risk, high return business. Despite the intrinsic risks, pharma companies continue to invest heavily in R&D to improve the quality of life of patients in needs of treatment. While capital is important in R&D outcomes, innovation-based organisations need to understand the best model to adopt to speed up the process in bringing discoveries to useful commercial …

5 minutes with Dr Subhadra Dravida, Founder and CEO of Transcell

Transcell Biologics is an innovative biotech company focuses in anti-cancer treatment, neurological ailments and autoimmune disorder. The innovative, stem cell based biotech company is based in Hyderabad, India. Ahead of this year’s BioPharma India 2016, we had the pleasure of grabbing a few minutes with its founder and CEO, Dr Subhadra Dravida.   What sparked the establishment of Transcell? We hope to translate stem cell …

Top 54 most influential individuals in India’s biopharma industry

After months of research and rounds of surveys , we have finalised the list of top 54 most influential individuals in India’s biopharma industry. Congratulations to our industry leaders from Biocon, Biological E, Dr Reddy’s Laboratories, Sun Pharma, Serum Institute of India, Cadila Healthcare, Lupin and many more. Simply click here to get your free copy of this ebook. You may also want …

IP, protection, IP protection, India, CDMO, IPR, intellectual property,

India on the radar for CDMO services

Prof. Dr. Rolf G. Werner, Professorship for Industrial Biotechnology, Eberhard Karls University of Tuebingen, Germany gave an in-depth presentation at last year’s BioPharma India Convention 2014 on CDMO services in India. In his presentation, Dr Werner covered: Intellectual property in India (pharma products) Current IPR regime in India Current India data protection regime Internal measures at CDMO Download presentation As IP …

Who are the top 50 leaders in India’s Biopharma industry?

In an effort to publish reliable and useful content for the members of our online community, we gather feedback from the industry to list outtop 50 most influential individuals in the current bio-pharmaceutical industry in India. This ebook is a complimentary effort by our BioPharma India Convention team to thank the industry for their continuous support in the past 13 years. An encouraging amount …

biopharma, biopharmaindia, india, manufacturing, cellculture, culture medium, media, media preparation, single-use, single-use technology, processing trends, biopharmaceutical processing, biopharmaceutical

Download: Powder Culture Media Packaging, Preparation and Market Trends

This whitepaper from Thermo Fisher reviews the impact from recent trends in biopharmaceutical processing on the usage of culture media and its packaging. Current media preparation problems, future trends, and alternatives to media prep practices are discussed. The findings and commentary from on-line survey of 24 large-scale culture media end-users together with in-depth phone interviews are presented to evaluate relevant …

India government launches its own brand to sell cheap generic drugs

India is well known to be one of the “workhorse” in generic production. Despite the comparable reasonably priced drugs in global market, the lower income population is still having difficulty in affording them during treatments. As an initiative to provide more holistic healthcare services for all, Indian government has decided to step in and control generic prices by purchasing and …

Download White Paper : Single Use Technology specifically designed for microbial fermentation

Single Use Technology is pretty much the one of the most talked about trend in the BioPharmaceutical Space. Within a doubt, this is one topic that has been constantly asked for by our attendees across the BioPharma Asia Pacific events. As we move quickly into the next phase for the BioPharma Asia Convention 2015, we look at some of the …

Download Ebook: Midsize Indian pharma/biotechs share their insights on the future

In PharmExec’s 10th Annual Report and Survey of BioPharmaceutical Manufacturing Capacity and Production, India stands as the 4th country preferred by pharmas to outsource manufacturing activities. As India builds its strength in biomanufacturing to become a global hub, we look at four India-based pharmaceutical companies and biotechs that have great potential for development and expansion within the local market. Despite …

Stemming The Flow Of Precursor Chemicals from India

  According to the 2010 International Narcotics Control Board (INCB) annual report, India is now the major source of diverted precursor chemicals. These chemicals are vital ingredients in the manufacture of narcotics such as amphetamine-type stimulants (ATS), methamphetamine, heroin and cocaine. The control of precursor chemicals is increasingly fundamental to the war against drugs. While precursor control was included in the United Nations 1988 Convention against the Illicit …